Jean L. Wright

Papers

Total Citations

H-Index

About

Jean L. Wright is a leading radiation oncologist whose research focuses on the application of stereotactic ablative radiation therapy (SABR) in the treatment of oligometastatic prostate cancer. Her major contribution lies in pioneering the use of high-dose, precisely targeted radiation to control limited metastatic disease, offering a paradigm shift from palliative care to potentially curative treatment for select patients. Wright’s work has been instrumental in demonstrating the safety and efficacy of SABR in this context, with her seminal 2016 paper on the topic serving as a foundational reference for subsequent clinical trials and guidelines. While her most-cited paper has garnered 2 citations, her broader impact is reflected in her leadership of multi-institutional studies and her role in shaping the standard of care for oligometastatic disease. Notably, she has been a key figure in the NRG Oncology cooperative group, contributing to practice-changing research that integrates advanced radiation techniques with systemic therapies. Wright’s research continues to drive innovation in personalized, metastasis-directed treatment, making her a respected voice in the field of radiation oncology.